Showing results (211-220 of 879) with videos related to
Sort By:
Pageof 88
Interactive Cardiovascular and Thoracic Surgery|August 3, 2007
Impact of coronary artery bypass grafting on survival after aortic valve replacementJ Mark Jones, Deidre Lovell, Gordon W Cran, et al.International Journal of Clinical Practice|June 30, 2010
Evaluation of NT-proBNP to predict outcomes in advanced heart failureG A MacGowan, D Neely, R Peaston, et al.The Journal of Antimicrobial Chemotherapy|August 5, 2010
Analyses of teicoplanin concentrations from 1994 to 2006 from a UK assay serviceC M Tobin, A M Lovering, E Sweeney, et al.Pediatric Research|May 7, 2008
Sildenafil acutely reverses the hypoxic pulmonary vasoconstriction response of the newborn pigRogerio Tessler, Shengping Wu, Renato Fiori, et al.Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|March 21, 2017
Motion compensated cine CMR of the fetal heart using radial undersampling and compressed sensingChristopher W Roy, Mike Seed, John C Kingdom, et al.Jac-Antimicrobial Resistance|February 6, 2023
The relationship between minimum inhibitory concentration and 28 day mortality in patients with a Gram-negative bloodstream infection: an analysis of data from a cohort study (BSI-FOO)Rebecca N Evans, Jessica Harris, Chris A Rogers, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 1, 2020
Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paperJ Turnidge, G Kahlmeter, R Cantón, et al.The Journal of Antimicrobial Chemotherapy|December 11, 1999
Exploration of the in-vitro pharmacodynamic activity of moxifloxacin for Staphylococcus aureus and Streptococci of lancefield groups A and GA P MacGowan, K E Bowker, M Wootton, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 22, 2002
The in vitro activity of moxifloxacin against Haemophilus influenzae and Moraxella catarrhalis explored using a pharmacodynamic modelAlasdair P. MacGowan, Karen E. Bowker, Mandy Wootton, et al.Antimicrobial Agents and Chemotherapy|October 7, 2009
Bacterial strain-to-strain variation in pharmacodynamic index magnitude, a hitherto unconsidered factor in establishing antibiotic clinical breakpointsAlasdair P MacGowan, Rosy Reynolds, Alan R Noel, et al.Pageof 88